Diversity-Oriented Synthesis Yields a New Drug Lead for Treatment of Chagas Disease
作者:Sivaraman Dandapani、Andrew R. Germain、Ivan Jewett、Sebastian le Quement、Jean-Charles Marie、Giovanni Muncipinto、Jeremy R. Duvall、Leigh C. Carmody、Jose R. Perez、Juan C. Engel、Jiri Gut、Danielle Kellar、Jair Lage Siqueira-Neto、James H. McKerrow、Marcel Kaiser、Ana Rodriguez、Michelle A. Palmer、Michael Foley、Stuart L. Schreiber、Benito Munoz
DOI:10.1021/ml400403u
日期:2014.2.13
A phenotypic high-throughput screen using approximately 100,000 compounds prepared using Diversity-Oriented Synthesis yielded stereoisomeric compounds with nanomolar growth-inhibition activity against the parasite Trypanosoma cruzi, the etiological agent of Chagas disease. After evaluating stereochemical dependence on solubility, plasma protein binding and microsomal stability, the SSS analogue (5)
[EN] NEW PROCESS FOR THE PREPARATION OF DRONEDARONE<br/>[FR] NOUVEAU PROCÉDÉ D'ÉLABORATION DE DRONÉDARONE
申请人:SANOFI SA
公开号:WO2011083346A1
公开(公告)日:2011-07-14
The subject of the present invention is a novel process for the preparation of N- [2-n-butyl-3-4-[(3-dibutylamino)propoxy]benzoyl}-1-benzofuran-5- yl] methanesulfonamide of formula (I) and the new intermediates of the reparation process.
[EN] GLYCOPROTEIN IIb/IIIa ANTAGONISTS<br/>[FR] ANTAGONISTES DE LA GLYCOPROTEINE IIb/IIIa
申请人:ELI LILLY AND COMPANY
公开号:WO1996022288A1
公开(公告)日:1996-07-25
(EN) This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, benzopyran, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.(FR) Cette invention se rapporte à certains composés bicycliques possédant un noyau constitué de deux cycles hexagonaux fusionnés, par exemple, benzopyrane, isoquinoline, isoquinolone, tétrahydronaphtalène, dihydronaphtalène ou tétralone, remplacés par une fonctionnalité à la fois basique et acide. Ces composés sont utilisés dans l'inhibition de l'agrégation plaquettaire.
This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, benzopyran, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.